Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Label-free in vitro assays predict the potency of anti-disialoganglioside chimeric antigen receptor T-cell products.
Logun M, Colonna MB, Mueller KP, Ventarapragada D, Rodier R, Tondepu C, Piscopo NJ, Das A, Chvatal S, Hayes HB, Capitini CM, Brat DJ, Kotanchek T, Edison AS, Saha K, Karumbaiah L. Logun M, et al. Among authors: capitini cm. Cytotherapy. 2023 Jun;25(6):670-682. doi: 10.1016/j.jcyt.2023.01.008. Epub 2023 Feb 26. Cytotherapy. 2023. PMID: 36849306 Free PMC article.
Production and characterization of virus-free, CRISPR-CAR T cells capable of inducing solid tumor regression.
Mueller KP, Piscopo NJ, Forsberg MH, Saraspe LA, Das A, Russell B, Smerchansky M, Cappabianca D, Shi L, Shankar K, Sarko L, Khajanchi N, La Vonne Denne N, Ramamurthy A, Ali A, Lazzarotto CR, Tsai SQ, Capitini CM, Saha K. Mueller KP, et al. Among authors: capitini cm. J Immunother Cancer. 2022 Sep;10(9):e004446. doi: 10.1136/jitc-2021-004446. J Immunother Cancer. 2022. PMID: 36382633 Free PMC article.
Metabolic priming of GD2 TRAC -CAR T cells during manufacturing promotes memory phenotypes while enhancing persistence.
Cappabianca D, Pham D, Forsberg MH, Bugel M, Tommasi A, Lauer A, Vidugiriene J, Hrdlicka B, McHale A, Sodji Q, Skala MC, Capitini CM, Saha K. Cappabianca D, et al. Among authors: capitini cm. bioRxiv [Preprint]. 2024 Mar 19:2024.01.31.575774. doi: 10.1101/2024.01.31.575774. bioRxiv. 2024. Update in: Mol Ther Methods Clin Dev. 2024 Apr 10;32(2):101249. doi: 10.1016/j.omtm.2024.101249 PMID: 38562720 Free PMC article. Updated. Preprint.
Virus-free CRISPR knock-in of a chimeric antigen receptor into KLRC1 generates potent GD2-specific natural killer cells.
Shankar K, Zingler-Hoslet I, Shi L, Katta V, Russell BE, Tsai SQ, Capitini CM, Saha K. Shankar K, et al. Among authors: capitini cm. bioRxiv [Preprint]. 2024 Feb 14:2024.02.14.580371. doi: 10.1101/2024.02.14.580371. bioRxiv. 2024. Update in: Mol Ther. 2025 Jan 14:S1525-0016(25)00028-0. doi: 10.1016/j.ymthe.2025.01.024 PMID: 38405747 Free PMC article. Updated. Preprint.
Generation of anti-GD2 CAR macrophages from human pluripotent stem cells for cancer immunotherapies.
Zhang J, Webster S, Duffin B, Bernstein MN, Steill J, Swanson S, Forsberg MH, Bolin J, Brown ME, Majumder A, Capitini CM, Stewart R, Thomson JA, Slukvin II. Zhang J, et al. Among authors: capitini cm. Stem Cell Reports. 2023 Feb 14;18(2):585-596. doi: 10.1016/j.stemcr.2022.12.012. Epub 2023 Jan 12. Stem Cell Reports. 2023. PMID: 36638788 Free PMC article.
83 results